Mefloquine: the benefits outweigh the risks
- 1 October 1996
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 42 (4) , 411-413
- https://doi.org/10.1111/j.1365-2125.1996.tb00002.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double‐blind, placebo‐controlled trialBritish Journal of Clinical Pharmacology, 1996
- The Safety of Antimalarial Drugs in PregnancyDrug Safety, 1996
- Conflicts of interest: the genesis of synthetic antimalarial agents in peace and warJournal of Antimicrobial Chemotherapy, 1995
- Malaria prophylaxisBMJ, 1995
- Fortnightly Review: Malaria prophylaxis: guidelines for travellers from BritainBMJ, 1995
- Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East AfricaThe Lancet, 1993
- Long-term malaria prophylaxis with weekly mefloquineThe Lancet, 1993
- Clinical Pharmacokinetics of MefloquineClinical Pharmacokinetics, 1990